Roche Holdings Ltd ADR (RHHBY)

$57.11 -0.59 (-1.02%)
Market Cap 367.58B
Revenue (ttm) 76.45B
Net Income (ttm) 15.54B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 18.12
Profit Margin 20.33%
Debt to Equity Ratio 1.00
Volume 3,509,200
Avg Vol 2,766,894
Day's Range N/A - N/A
Shares Out 6.37B
Stochastic %K 76%
Beta 0.44
Analysts Sell
Price Target $52.72

Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer,...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 41 61 688 88 80
Fax: 41 61 691 00 14
Address:
Grenzacherstrasse 124, Basel, Switzerland
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 26 at 7:12 PM
$SLS $ABBV $RHHBY - 47 days Since the 78th Event PR - 22 Days Per EVENT Rate. 80th Event and Ensuing Share Price LAUNCH is Now Truly imminent.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 26 at 3:57 PM
$SLS Gps Treatment ARM MOS is now > 31.5 Months BAT / Aza+VEN $ABBV $RHHBY Failed 3 AML Remission maintenance Trials. VIALE-M CR1 Remission Maintenance Phase 3 Trial Failed VIALE-T Post Transplant Maintenance Phase 3 Trial Failed - Last week PH2/ low dose, all Oral combo - FAILED This $12 Stock is going to be a $100 Stock and More. Mark this Post. Smart Money Knows. ​$ABBV up $25B in Market Value Last 2 Days...
0 · Reply
LibertarianTreehugger
LibertarianTreehugger Jun. 25 at 5:59 PM
Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Why the Stock Impact May Be More Limited Than It Looks: https://www.fool.com/investing/2026/06/23/jazz-pharmaceuticals-lung-cancer-drug-setback-in-l/ $JAZZ $RHHBY
0 · Reply
biotech
biotech Jun. 25 at 4:24 PM
$SGMO $SGMO The Bidding War: $LLY vs. Genentech/ $RHHBY Roche If $BIIB data in July proves that stopping tau is the holy grail for curing Alzheimer's these giant companies will look at Sangamo’s safe permanent "Zinc Finger" switch and realize they need to buy it ad then STAC-BBB
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 24 at 7:12 PM
$SLS SMART Money will be Surging into Position on the 80th Event PR --- 80th Event and Share Price Launch now truly Imminent. - the reason the Share Price Launched on each of the Previous Event PR's, is the Same Reason, it will Just about double to $18/ $20 on the 80th. That is - SMART MONEY ... Much Smarter than US ( $ABBV / $RHHBY $BMY) Knows BAT does not offer effective Remission Maintenance - they Know its Gps Doing what its done in all 7 Prior Trials - Prevent Relapse and Extend Survival - Directly Correlated with Immune Response- SMART Money will be Surging into Position on the 80th Event PR --- 80th Event and Share Price Launch now truly Imminent. The IDMC UNBLINDED ACTUAL PHASE 3 MOS and IR DATA From the INTERIM ANALYSIS at 60 Events.. - penny flipping idiots are going regret for the rest of their Miserable Short Lives, for selling for anything less than $100 Per Share - now you know.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 24 at 6:31 PM
$SLS IDMC UNBLINDED ACTUAL MOS AND IR DATA FROM THIS ONGOING P3 INTERIM ANALYSIS - Only inch thick tools don’t get it Now 47 Days since the 78th Event 72nd Dec 26th - 78th May 11 --- 6 Events in 136 Days / Approximately 1 Event Every 22 Days - > Monday was the Bullseye 4 the 80th Event PR. - and the reason the Share Price Launched on each of the Previous Event PR's, is the Same Reason, it will Just about double to $18/ $20 on the 80th. That is - SMART MONEY ... Much Smarter than US ( $ABBV / $RHHBY $BMY) Knows BAT does not offer effective Remission Maintenance - they Know its Gps Doing what its done in all 7 Prior Trials - Prevent Relapse and Extend Survival - Directly Correlated with Immune Response- The IDMC UNBLINDED ACTUAL PHASE 3 MOS and IR DATA From the INTERIM ANALYSIS at 60 Events.. penny flipping idiots are going regret for the rest of your Miserable Short Lives, for selling for anything less than $100 Per Share - now you know. https://www.cancernetwork.com/view/galinpepimut-s-completes-phase-3-regal-interim-analysis-in-aml
0 · Reply
DidYouReadThis
DidYouReadThis Jun. 23 at 8:31 PM
DD super readers, what companies to you predict to be a potential buy out target by 2030 whether by $PFE, $RHHBY $ABBV $LLY or a different co?
0 · Reply
scotttrader213
scotttrader213 Jun. 23 at 11:59 AM
$RHHBY major disappointment for 2026.
0 · Reply
scotttrader213
scotttrader213 Jun. 23 at 1:46 AM
$NVO finally, the street, is realizing, $NVO has upside strength, and a pipeline which is very promising. Now, if only $RHHBY stratwe to move forward..
0 · Reply
DidYouReadThis
DidYouReadThis Jun. 22 at 6:36 PM
Which #quarter do you expect strongest #earnings for number of #wetAMD #injections? $RHHBY $BAYRY $REGN Good luck $OTLK on your #PDUFA Wednesday, July 29, 2026!
0 · Reply
Latest News on RHHBY
No data available.
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 26 at 7:12 PM
$SLS $ABBV $RHHBY - 47 days Since the 78th Event PR - 22 Days Per EVENT Rate. 80th Event and Ensuing Share Price LAUNCH is Now Truly imminent.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 26 at 3:57 PM
$SLS Gps Treatment ARM MOS is now > 31.5 Months BAT / Aza+VEN $ABBV $RHHBY Failed 3 AML Remission maintenance Trials. VIALE-M CR1 Remission Maintenance Phase 3 Trial Failed VIALE-T Post Transplant Maintenance Phase 3 Trial Failed - Last week PH2/ low dose, all Oral combo - FAILED This $12 Stock is going to be a $100 Stock and More. Mark this Post. Smart Money Knows. ​$ABBV up $25B in Market Value Last 2 Days...
0 · Reply
LibertarianTreehugger
LibertarianTreehugger Jun. 25 at 5:59 PM
Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Why the Stock Impact May Be More Limited Than It Looks: https://www.fool.com/investing/2026/06/23/jazz-pharmaceuticals-lung-cancer-drug-setback-in-l/ $JAZZ $RHHBY
0 · Reply
biotech
biotech Jun. 25 at 4:24 PM
$SGMO $SGMO The Bidding War: $LLY vs. Genentech/ $RHHBY Roche If $BIIB data in July proves that stopping tau is the holy grail for curing Alzheimer's these giant companies will look at Sangamo’s safe permanent "Zinc Finger" switch and realize they need to buy it ad then STAC-BBB
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 24 at 7:12 PM
$SLS SMART Money will be Surging into Position on the 80th Event PR --- 80th Event and Share Price Launch now truly Imminent. - the reason the Share Price Launched on each of the Previous Event PR's, is the Same Reason, it will Just about double to $18/ $20 on the 80th. That is - SMART MONEY ... Much Smarter than US ( $ABBV / $RHHBY $BMY) Knows BAT does not offer effective Remission Maintenance - they Know its Gps Doing what its done in all 7 Prior Trials - Prevent Relapse and Extend Survival - Directly Correlated with Immune Response- SMART Money will be Surging into Position on the 80th Event PR --- 80th Event and Share Price Launch now truly Imminent. The IDMC UNBLINDED ACTUAL PHASE 3 MOS and IR DATA From the INTERIM ANALYSIS at 60 Events.. - penny flipping idiots are going regret for the rest of their Miserable Short Lives, for selling for anything less than $100 Per Share - now you know.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 24 at 6:31 PM
$SLS IDMC UNBLINDED ACTUAL MOS AND IR DATA FROM THIS ONGOING P3 INTERIM ANALYSIS - Only inch thick tools don’t get it Now 47 Days since the 78th Event 72nd Dec 26th - 78th May 11 --- 6 Events in 136 Days / Approximately 1 Event Every 22 Days - > Monday was the Bullseye 4 the 80th Event PR. - and the reason the Share Price Launched on each of the Previous Event PR's, is the Same Reason, it will Just about double to $18/ $20 on the 80th. That is - SMART MONEY ... Much Smarter than US ( $ABBV / $RHHBY $BMY) Knows BAT does not offer effective Remission Maintenance - they Know its Gps Doing what its done in all 7 Prior Trials - Prevent Relapse and Extend Survival - Directly Correlated with Immune Response- The IDMC UNBLINDED ACTUAL PHASE 3 MOS and IR DATA From the INTERIM ANALYSIS at 60 Events.. penny flipping idiots are going regret for the rest of your Miserable Short Lives, for selling for anything less than $100 Per Share - now you know. https://www.cancernetwork.com/view/galinpepimut-s-completes-phase-3-regal-interim-analysis-in-aml
0 · Reply
DidYouReadThis
DidYouReadThis Jun. 23 at 8:31 PM
DD super readers, what companies to you predict to be a potential buy out target by 2030 whether by $PFE, $RHHBY $ABBV $LLY or a different co?
0 · Reply
scotttrader213
scotttrader213 Jun. 23 at 11:59 AM
$RHHBY major disappointment for 2026.
0 · Reply
scotttrader213
scotttrader213 Jun. 23 at 1:46 AM
$NVO finally, the street, is realizing, $NVO has upside strength, and a pipeline which is very promising. Now, if only $RHHBY stratwe to move forward..
0 · Reply
DidYouReadThis
DidYouReadThis Jun. 22 at 6:36 PM
Which #quarter do you expect strongest #earnings for number of #wetAMD #injections? $RHHBY $BAYRY $REGN Good luck $OTLK on your #PDUFA Wednesday, July 29, 2026!
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 22 at 3:48 PM
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis $QNTM QNTM.CN $SNY $RHHBY $BIIB $CLNN https://ibn.fm/cVNcf
1 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 22 at 5:26 AM
$SLS $ABBV $RHHBY $BMY 72nd to 78th - 22 Days Per Event - tomorrow its the 44th day since the 78th occurred. IMMINENT Gps is about to get an FDA Green light worth $40B to Big Pharma.
0 · Reply
Mike22332233
Mike22332233 Jun. 21 at 12:16 PM
$RHHBY Was there a report out (i don’t know, maybe in the FT) of a rumor that ROCHE would be buying out SLS? If anyone knows anything, please comment. Thank You
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 21 at 8:53 AM
$SLS Monday will be the 44th Day since the 78th Event. 72nd Dec 26th - 78th May 11 --- 6 Events in 136 Days / Approximately 1 Event Every 22 Days... -- > Monday is the Bullseye to see the 80th Event PR - and for the INCH THICK IDIOT Tools, the reason the Share Price Launched on each of the Previous Event PR's, is the Same Reason, it will Just about double to $18/ $20 on the 80th ... That is - SMART MONEY ... Much Smarter than US ( $ABBV / $RHHBY $BMY) Knows BAT does not offer effective Remission Maintenance - they Know its Gps Doing what its done in all 7 Prior Trials --- Prevent Relapse and Extend Survival - that is Directly Correlated with Immune Response- The IDMC UNBLINDED ACTUAL PHASE 3 MOS and IR DATA From the INTERIM ANALYSIS at 60 Events... You penny flipping idiots are going regret for the rest of your Miserable Short Lives, for selling for anything less than $80 Per Share --- now you know.
0 · Reply
wwmeinc
wwmeinc Jun. 20 at 8:54 PM
$VKTX .... $RHHBY $MRK $ABBV $PFE I kind of forgot just how many times within the last 12 months or less the FT.COM has started the biotech 'rumour mill' ...not bad really...after which either bankers or lawyers(forgot which one)penned an opinion piece in the FT complaining that these 'leaks' were costing the buyer money...huh! Surprise, surprise....no matter, good sources vs loose lips....the end results is great news for the target shareholders in question. Gemini has 'chimed in'.....ok...prompted ;) glta "The Verdict on Certainty....If AbbVie consolidates a position by pursuing Apogee, Roche and Merck emerge with the highest certainty for a potential Viking takeover. Both possess more than enough cash on hand to fund an all-cash premium deal and have an urgent, unfilled long-term strategic need for an advanced Phase 3 metabolic drug."
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 20 at 6:50 PM
$SLS Monday will be the 44th Day since the 78th Event. 72nd Dec 26th - 78th May 11 --- 6 Events in 136 Days / Approximately 1 Event Every 22 Days... -- > Monday is the Bullseye to see the 80th Event PR - and for the INCH THICK IDIOT Tools, the reason the Share Price Launched on each of the Previous Event PR's, is the SAME REASON, it will Just about double to $18/ $20 on the 80th ... That is - SMART MONEY ... Much Smarter than US ( $ABBV / $RHHBY $BMY) Knows BAT does not offer effective Remission Maintenance - they Know its Gps Doing what its done in all 7 Prior Trials --- Prevent Relapse and Extend Survival - that is Directly Correlated with Immune Response- The IDMC UNBLINDED ACTUAL PHASE 3 MOS and IR DATA From the INTERIM ANALYSIS at 60 Events... You dumb as f, penny flipping, lemming idiots are going regret for the rest of your Miserable Short Lives, for selling for anything less than $80 Per Share --- now you know.
1 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 20 at 6:48 PM
$SLS $ABBV $RHHBY $BMY As I posted Thursday - ANGIE - May Like to Surprise the STREET and Serve these Lying short SCUMBAGS with a tasty Amuse-Bouche - and announce the 80th Event and while also Disclosing the Number of EVENTS in the BAT and GPS Treatment Arms --- 55-60 / 20-25 --- --- as the IDMC has that DATA Immediately Upon the 80th.
1 · Reply
JohnPDaly
JohnPDaly Jun. 20 at 12:43 PM
$LCTX $RHHBY https://x.com/johnpdalyjr/status/2068313537307390185?s=12
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 20 at 7:18 AM
$SLS $ABBV $RHHBY $BMY IDMC UNBLINDED ACTUAL MOS AND IR DATA FROM THIS ONGOING P3 INTERIM ANALYSIS… Only inch thick tools don’t get it.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 19 at 7:01 PM
$SLS $ABBV $RHHBY $BMY have Long Term VIALE-C, VIALE-M VIALE-T Phase 3 Data - for PATIENTS IN TRIAL - Getting Extra Ordinary In Trial Treatment ... There is NIL Survival beyond 20 months for any AML CR2 Patients, on BAT, ABSENT TRANSPLANT. - *** Ask any of the SHORT LYING LOWLIFE SCUMBAGS to Show You 1 - Just 1 Trial - with IN TRIAL Patients, ALL r/R AML who obtain a Second Remission CR2 - Which WILL INCLUDE ANY- SO CALLED - Healthiest transplant Ineligible Patients - with any Survival Past 20 months ... -- You'll Get CRICKETs. As I posted Yesterday - ANGIE - May Like to Surprise the STREET and Plug these SCUMBAGS with a tasty Amuse-Bouche - and DISCLOSE the 80th Event and include the Number of EVENTS in the BAT and GPS Treatment Arms --- 55-60 / 20-25 --- --- as the IDMC has that DATA Immediately Upon the 80th.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 18 at 9:19 PM
$SLS Monday will be the 44th Day since the 78th Event. 72nd Dec 26th - 78th May 11 --- 6 Events in 136 Days / Approximately 1 Event Every 22 Days... -- > Monday is the Bullseye to see the 80th Event PR - and for the INCH THICK IDIOT Tools, the reason the Share Price Launched on each of the Previous Event PR's, is the Same Reason, it will Just about double to $18/ $20 on the 80th ... That is - SMART MONEY ... Much Smarter than US ( $ABBV / $RHHBY $BMY) Knows BAT does not offer effective Remission Maintenance - they Know its Gps Doing what its done in all 7 Prior Trials --- Prevent Relapse and Extend Survival - that is Directly Correlated with Immune Response- The IDMC UNBLINDED ACTUAL PHASE 3 MOS and IR DATA From the INTERIM ANALYSIS at 60 Events... You penny flipping idiots are going regret for the rest of your Miserable Short Lives, for selling for anything less than $80 Per Share --- now you know.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jun. 18 at 6:32 PM
$SLS Monday will be the 44th Day since the 78th Event. 72nd Dec 26th - 78th May 11 --- 6 Events in 136 Days / Approximately 1 Event Every 22 Days... -- > Monday is the Bullseye to see the 80th Event PR - and for this Board Full of INCH THICK IDIOT Tools, the reason the Share Price Launched on each of the Previous Event PR's, is the Same Reason, it will Just about double to $18/ $20 on the 80th ... That is - SMART MONEY ... Much Smarter than US ( $ABBV / $RHHBY $BMY) Knows BAT does not offer effective Remission Maintenance - they Know its Gps Doing what its done in all 7 Prior Trials --- Prevent Relapse and Extend Survival - that is Directly Correlated with Immune Response- The IDMC UNBLINDED ACTUAL PHASE 3 MOS and IR DATA From the INTERIM ANALYSIS at 60 Events... You penny flipping idiots are going regret for the rest of your Miserable Short Lives, for selling for anything less than $80 Per Share --- now you know.
0 · Reply